首页 / 院系成果 / 成果详情页

Target Trial Emulation of Severe Acute Respiratory Syndrome Coronavirus 2 Infection Versus No Infection and Risk of Post-Coronavirus Disease 2019 Conditions in the Omicron Variant Versus Prior Eras  期刊论文  

  • 编号:
    826DE0BE877AA0D9AC8B127EFEE2B3A3
  • 作者:
    Ioannou, George N.[1,2,3] Berry, Kristin[1] Rajeevan, Nallakkandi[4,5] Li, Yuli[4] Yan, Lei[4,6] Huang, Yuan[4,6] Bui, David[7] Hynes, Denise M.[8,9,10] Rowneki, Mazhgan[8] Hickok, Alex[8,11] Niederhausen, Meike[11,12,13] Shahoumian, Troy A.[14] Bohnert, Amy[15,16] Boyko, Edward J. Korpak, Anna[17] Fox, Alexandra[17] Baraff, Aaron[17] Iwashyna, Theodore J.[18,19] Maciejewski, Matthew L.[20,21,22,23] Smith, Valerie A.[20,21,22,23] Berkowitz, Theodore S. Z.[15,20] Pura, John A.[20] Hebert, Paul[24,25] Wong, Edwin S.[24,25] O''Hare, Ann M.[24,26] Osborne, Thomas F.[27,28] Viglianti, Elizabeth M.[15,29] Aslan, Mihaela[4,30] Bajema, Kristina L.[7,31]
  • 语种:
    英文
  • 期刊:
    CLINICAL INFECTIOUS DISEASES ISSN:1058-4838 2025 年 ; 2025 APR 10
  • 疾病分类:
    传染性非典型肺炎、新型冠状病毒肺炎
  • 关键词:
  • 摘要:

    Background Coronavirus disease 2019 (COVID-19) has been linked to the development of post-COVID-19 conditions (PCCs). We investigated whether severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection increases the risk of selected PCCs or death up to 1 year after infection, separately in the wild-type (WT), Alpha-transition, Delta, and Omicron eras and by vaccination status.Methods We used health records of the Veterans Health Administration to emulate a hypothetical target trial of SARS-CoV-2 infection versus no infection. Veterans who tested positive for SARS-CoV-2 between March 2020 and April 2022 (n = 430 160) were matched 1:1 to veterans who had not tested positive for SARS-CoV-2. All-cause mortality and cumulative incidence of 32 potential PCCs were ascertained at 31-180 and 181-365 days after infection or matched index date.Results From 31 to 180 days, the cumulative incidence of death and all organ-level PCCs was greater in infected versus uninfected participants, with cumulative incidence differences lower in the Omicron than in the WT era and lower in vaccinated than in unvaccinated persons. In the Omicron era, the cumulative incidence of death and most PCCs from day 181-365 were higher in infected than in uninfected participants only among unvaccinated but not among vaccinated persons.Conclusions Excess burden of PCCs and mortality persisted 31-180 days after infection in the Omicron era, albeit at a lower level than in the WT and Delta eras. Excess burden of mortality and most PCCs was much lower 181-365 days after infection and was observed in the Omicron era only among unvaccinated persons, suggesting a protective effect of vaccination. The excess burden of mortality and post-coronavirus disease 2019 conditions was lower in Omicron than in wild-type and Delta eras, lower in vaccinated than in unvaccinated persons, and much lower 181-365 days than 31-180 days after infection.

  • 推荐引用方式
    GB/T 7714:
    Ioannou George N.,Berry Kristin,Rajeevan Nallakkandi, et al. Target Trial Emulation of Severe Acute Respiratory Syndrome Coronavirus 2 Infection Versus No Infection and Risk of Post-Coronavirus Disease 2019 Conditions in the Omicron Variant Versus Prior Eras [J].CLINICAL INFECTIOUS DISEASES,2025.
  • APA:
    Ioannou George N.,Berry Kristin,Rajeevan Nallakkandi,Li Yuli,&Bajema Kristina L..(2025).Target Trial Emulation of Severe Acute Respiratory Syndrome Coronavirus 2 Infection Versus No Infection and Risk of Post-Coronavirus Disease 2019 Conditions in the Omicron Variant Versus Prior Eras .CLINICAL INFECTIOUS DISEASES.
  • MLA:
    Ioannou George N., et al. "Target Trial Emulation of Severe Acute Respiratory Syndrome Coronavirus 2 Infection Versus No Infection and Risk of Post-Coronavirus Disease 2019 Conditions in the Omicron Variant Versus Prior Eras" .CLINICAL INFECTIOUS DISEASES(2025).
  • 数据来源自科睿唯安Web of Science核心合集
  • 入库时间:
    2025/5/14 12:03:34
  • 更新时间:
    2025/5/14 12:03:34
浏览次数:4 下载次数:0
浏览次数:4
下载次数:0
打印次数:0
浏览器支持: Google Chrome   火狐   360浏览器极速模式(8.0+极速模式) 
返回顶部